Diffuse large B-cell lymphoma trials in Italy

In Italy 34 Also abroad 346

34 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
Where
Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche, Florence, Milan, Padova, Sassuolo, Siena, Torino, Treviso, Tricase, Trieste, Verona
Age
18 years to 79 years
People
200
Run by
Fondazione Italiana Linfomi - ETS
See details and how to joinNCT06588205
No phaseTaking people
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
Where
Bologna, Meldola, Ravenna, Rimini
Age
18 years and over
People
300
Run by
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT04300101
Phase 2Taking people
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
Where
Alexandria, Bologna, Cuneo, Milan, Rome, Rozzano
Age
18 years to 99 years
People
50
Run by
Istituto Clinico Humanitas
See details and how to joinNCT06918912 · EU 2024-516929-31-00
No phaseTaking people
Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
Where
Bologna
Age
18 years and over
People
160
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06774326
Phase 3Taking people
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Where
Aviano, Bari, Milan, Monza, Naples, Orbassano, Reggio Calabria, Rome, Trieste, Udine, Verona
Age
75 years and over
People
300 worldwide
Run by
Nordic Lymphoma Group
See details and how to joinNCT04332822 · EU 2022-502887-19-00
No phaseTaking people
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Where
Milan
Age
18 years and over
People
200
Run by
Incyte Biosciences Italy S.r.l
See details and how to joinNCT06299553
No phaseNot yet taking people in Italy
Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)
Where
Naples, Roma
Age
18 years and over
People
300
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT05746858
Phase 3Taking people
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Where
Alexandria, Ancona, Andria, Ascoli Piceno, Avellino, Aviano, Brescia, Cagliari, Chivasso, Florence, Meldola, Milan, Monza, Novara, Palermo, Pavia, Perugia, Pescara, Piacenza, Ponderano, Potenza, Ravenna, Reggio Emilia, Rimini, Rionero In Vulture, Roma, Rome, Salerno, San Giovanni Rotondo, Sassuolo, Siena, Terni, Trieste, Turin, Udine, Venice, Vicenza
Age
65 years and over
People
430
Run by
Fondazione Italiana Linfomi - ETS
See details and how to joinNCT04442412 · EU 2024-511637-35-00
Phase 1/2Taking people
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Where
Aviano, Meldola, Milan, Pavia, Verona
Age
18 years and over
People
84 worldwide
Run by
Kartos Therapeutics, Inc.
See details and how to joinNCT04502394